Edmond De Rothschild Holding S.A. Alnylam Pharmaceuticals, Inc. Transaction History

Edmond De Rothschild Holding S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$143.31 - $247.0 $1.72 Million - $2.96 Million	-12,000 Reduced 18.45%	53,050 $12.9 Million
Q1 2024 May 08, 2024	BUY	$146.51 - $198.2 $7.22 Million - $9.76 Million	49,250 Added 311.71%	65,050 $9.72 Million
Q4 2023 Feb 12, 2024	BUY	$151.41 - $196.57 $2.39 Million - $3.11 Million	15,800 New	15,800 $3.02 Million
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $13,035 - $18,372	-208 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$72.53 - $118.27 $15,086 - $24,600	208	208 $24,000

641

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $28.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Edmond De Rothschild Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Edmond De Rothschild Holding S.A. with notifications on news.